Search by Drug Name or NDC

    NDC 00310-3040-00 SAPHNELO 300 mg/2mL Details

    SAPHNELO 300 mg/2mL

    SAPHNELO is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AstraZeneca Pharmaceuticals LP. The primary component is ANIFROLUMAB.

    Product Information

    NDC 00310-3040
    Product ID 0310-3040_3f2b76dd-4c0c-4d2c-ba03-762f92b00153
    Associated GPIs 99427010252020
    GCN Sequence Number 082546
    GCN Sequence Number Description anifrolumab-fnia VIAL 300 MG/2ML INTRAVEN
    HIC3 Z25
    HIC3 Description IMMUNOSUPPRESSANT-INTERFERON INHIBITOR, MAB
    GCN 49997
    HICL Sequence Number 047512
    HICL Sequence Number Description ANIFROLUMAB-FNIA
    Brand/Generic Brand
    Proprietary Name SAPHNELO
    Proprietary Name Suffix n/a
    Non-Proprietary Name Anifrolumab
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 300
    Active Ingredient Units mg/2mL
    Substance Name ANIFROLUMAB
    Labeler Name AstraZeneca Pharmaceuticals LP
    Pharmaceutical Class Type I Interferon Receptor Antagonist [EPC], Type I Interferon Receptor Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761123
    Listing Certified Through 2024-12-31

    Package

    NDC 00310-3040-00 (00310304000)

    NDC Package Code 0310-3040-00
    Billing NDC 00310304000
    Package 1 VIAL, GLASS in 1 CARTON (0310-3040-00) / 2 mL in 1 VIAL, GLASS
    Marketing Start Date 2021-07-30
    NDC Exclude Flag N
    Pricing Information N/A